BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22807982)

  • 1. Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.
    Li W; Liu ML; Cai JH; Tang YX; Zhai LY; Zhang J
    Oncol Lett; 2012 Jul; 4(1):168-174. PubMed ID: 22807982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts.
    Li W; Tang YX; Wan L; Cai JH; Zhang J
    Oncol Lett; 2013 Mar; 5(3):923-928. PubMed ID: 23426648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.
    Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J
    Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.
    Li W; Wan L; Zhai LY; Wang J
    Int J Mol Sci; 2014 Oct; 15(10):19265-80. PubMed ID: 25342321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.
    Li W; Cai JH; Zhang J; Tang YX; Wan L
    Int J Mol Sci; 2012; 13(8):9741-9753. PubMed ID: 22949827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.
    Li W; Wang J; Jiang HR; Xu XL; Zhang J; Liu ML; Zhai LY
    Int J Mol Sci; 2011 Jan; 12(1):668-81. PubMed ID: 21340007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
    Li W; Xu RJ; Lin ZY; Zhuo GC; Zhang HH
    Med Oncol; 2009; 26(2):170-7. PubMed ID: 18988002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1alpha (HIF-1alpha) correlated with tumor growth and apoptosis in ovarian cancer.
    Jiang H; Feng Y
    Int J Gynecol Cancer; 2006; 16 Suppl 1():405-12. PubMed ID: 16515634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo.
    Li W; Zhang HH; Xu RJ; Zhuo GC; Hu YQ; Li J
    Med Oncol; 2008; 25(2):172-7. PubMed ID: 18488158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.
    Li W; Ji ZL; Zhuo GC; Xu RJ; Wang J; Jiang HR
    Med Oncol; 2010 Mar; 27(1):98-104. PubMed ID: 19235530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
    Fan YZ; Chen CQ; Zhao ZM; Sun W
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
    Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
    Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
    J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential combination of flavopiridol with Taxol synergistically suppresses human ovarian carcinoma growth.
    Song Y; Xin X; Zhai X; Xia Z; Shen K
    Arch Gynecol Obstet; 2015 Jan; 291(1):143-50. PubMed ID: 25118834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
    Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
    J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of endostatin combined with paclitaxel-cisplatin on breast cancer in xenograft-bearing mice.
    Sun J; Deng L; Duan Y; Chen F; Wang X; Li D; Chen Z
    Exp Ther Med; 2012 Feb; 3(2):159-164. PubMed ID: 22969862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.